Figure 2 — Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status

Navigate

Research Paper|Volume 13, Issue 7|pp. 9225–9242

Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status

Back to articleFigure 2(3 of 3)

100%

Figure 2.Subgroup analysis for systemic and venous thromboembolism. (A) Systemic thromboembolism (n=37); (B) Venous thromboembolism (n=45). * AF: atrial fibrillation. HR: hazard ratio. CI: confidential interval.

Figure 2 — Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status | Aging